Kelvin Kapungu
Overview
Explore the profile of Kelvin Kapungu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vallely L, Kapungu K, Mengi A, Chaponda M, Chico R, Riddell M, et al.
PLOS Glob Public Health
. 2024 Jul;
4(7):e0003441.
PMID: 39084601
Curable sexually transmitted infections (STIs) are neglected in public health policy, services and society at large. Effective interventions are available for some STI but seem not to be prioritised at...
2.
Carcelen A, Prosperi C, Hamahuwa M, Kapungu K, Chongwe G, Mwansa F, et al.
PLOS Glob Public Health
. 2024 Jun;
4(6):e0002985.
PMID: 38941295
Nested serosurveys within routine service delivery platforms such as planned supplemental immunization activities (SIAs) provide an opportunity to collect information that can be used to answer valuable questions on the...
3.
Scarsi K, Sayles H, Kapungu K, Sifuna P, Ippolito M, Furl R, et al.
Am J Trop Med Hyg
. 2023 Aug;
109(4):752-760.
PMID: 37604474
Antimalarial medications are recommended for chemoprevention as part of malaria control programs to decrease the morbidity and mortality related to more than 200 million infections each year. We sought to...
4.
Podewils L, Long E, Fuller T, Mwakazanga D, Kapungu K, Tembo M, et al.
BMC Public Health
. 2022 Apr;
22(1):791.
PMID: 35439984
Background: Mineworkers in Southern Africa have the highest rates of tuberculosis (TB) among working populations in the world (The World Bank, Benefits and costs associated with reducing tuberculosis among Southern...
5.
Carcelen A, Prosperi C, Mutembo S, Chongwe G, Mwansa F, Ndubani P, et al.
Hum Vaccin Immunother
. 2021 Jul;
18(1):1-6.
PMID: 34227914
With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old...
6.
Melgar M, Shiraishi R, Tende C, Mwanza S, Mulenga J, Khondowe S, et al.
BMC Public Health
. 2021 May;
21(1):859.
PMID: 33947361
Background: The Ministry of Health Zambia recommends tuberculosis preventive treatment (TPT) with 6 months daily isoniazid for all people living with human immunodeficiency virus (HIV) after ruling out active tuberculosis...